X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864399/0/en/Alterity-Therapeutics-Parkinson-s-Disease-and-Multiple-System-Atrophy-Data-Featured-at-the-American-Academy-of-Neurology-AAN-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/10/2860644/0/en/Alterity-Therapeutics-to-Present-New-Data-on-ATH434-at-the-World-Orphan-Drug-Congress-USA-2024.html
https://www.globenewswire.com/news-release/2024/03/26/2852507/0/en/Alterity-Therapeutics-Receives-a-A-3-9-Million-Research-Development-Tax-Incentive-Refund.html
https://www.globenewswire.com//news-release/2024/02/20/2832033/0/en/Alterity-Therapeutics-to-Present-New-Data-at-the-Upcoming-American-Academy-of-Neurology-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/06/2824180/0/en/Alterity-Therapeutics-Phase-2-Data-Monitoring-Committee-Recommends-Continuing-Clinical-Trial-as-Planned-After-Second-Review.html
https://www.globenewswire.com/news-release/2024/01/29/2818784/0/en/Alterity-Therapeutics-to-Participate-in-the-ShareCafe-Hidden-Gems-Webinar-This-Week.html
https://www.globenewswire.com//news-release/2024/01/22/2812929/0/en/Alterity-Therapeutics-Issues-Shareholder-Letter-Highlighting-Pipeline-Advances-and-Key-Upcoming-Milestones.html
https://www.globenewswire.com//news-release/2023/12/21/2799746/0/en/Alterity-Therapeutics-Appoints-Phillip-Hains-as-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2023/12/04/2789905/0/en/Alterity-Therapeutics-Reports-Positive-Efficacy-Data-for-ATH434-in-a-Primate-Model-of-Parkinson-s-Disease.html
https://www.globenewswire.com//news-release/2023/11/27/2786053/0/en/Alterity-Therapeutics-Announces-Presentation-of-Novel-Biomarker-Data-for-Evaluation-of-Multiple-System-Atrophy.html
Market Place
Share 
